Ascendis Pharma AS (ASND) ADR

Sell:$149.77Buy:$150.22$1.52 (1.00%)

NASDAQ:5.97%
Market closed | Prices delayed by at least 15 minutes
Sell:$149.77
Buy:$150.22
Change:$1.52 (1.00%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$149.77
Buy:$150.22
Change:$1.52 (1.00%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Key people

Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
Scott T. Smith
Chief Financial Officer, Executive Vice President, Member of the Executive Board
Lotte Soenderbjerg
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Aimee Shu,
Executive Vice President, Chief Medical Officer
Stina Singel
Executive Vice President, Head of Clinical Development, Oncology
Kennett Sprogoee
Executive Vice President, Head of Innovation and Research
Donovan Wu
Executive Vice President, U.S. President
Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Albert Cha
Independent Chairman of the Board
Lisa Bright
Independent Director
William Carl Fairey
Independent Director
Lars Holtug
Independent Director
Siham Imani
Independent Director
Click to see more

Key facts

  • EPIC
    ASND
  • Location
    Denmark
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US04351P1012
  • Market cap
    $9.19bn
  • Employees
    1,017
  • Shares in issue
    61.54m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.